Hormonal implants: Contraception for a new century

[1]  J. Geelen,et al.  Release kinetics of 3-keto-desogestrel from contraceptive implants (Implanon) in dogs: comparison with in vitro data. , 1993, Contraception.

[2]  E. Coutinho,et al.  One year contraception with a single subdermal implant containing nomegestrol acetate (Uniplant). , 1993, Contraception.

[3]  S. Monroe,et al.  Evaluation of a 1-year levonorgestrel-releasing contraceptive implant: side effects, release rates, and biodegradability , 1992 .

[4]  D. Mishell,et al.  Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices. , 1992, American journal of obstetrics and gynecology.

[5]  O. Heikinheimo,et al.  Contraception with subdermal implants releasing the progestin ST-1435: a dose-finding study. , 1992, Contraception.

[6]  C. Bardin,et al.  Clinical trial with 3-keto-desogestrel subdermal implants. , 1991, Contraception.

[7]  P. Vilja,et al.  Norplant implants: the mechanism of contraceptive action. , 1991, Fertility and sterility.

[8]  E. Otolorin,et al.  Changes in carbohydrate metabolism during 30 months on Norplant. , 1991, Contraception.

[9]  A. Faúndes,et al.  Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants. , 1991, Fertility and sterility.

[10]  D. Mishell,et al.  The Significance of Bleeding Patterns in Norplant Implant Users , 1991, Obstetrics and gynecology.

[11]  V. Beral,et al.  Contraception and ectopic pregnancy risk. , 1990, American Journal of Obstetrics and Gynecology.

[12]  V. Odlind,et al.  Clinical results with subcutaneous implants containing 3-keto desogestrel. , 1990, Contraception.

[13]  P. Darney,et al.  Acceptance and perceptions of NORPLANT among users in San Francisco, USA. , 1990, Studies in family planning.

[14]  A. Faúndes,et al.  Ovarian endocrine function through five years of continuous treatment with NORPLANT subdermal contraceptive implants. , 1990, Contraception.

[15]  Darney Pd,et al.  Sustained-release contraceptives. , 1990 .

[16]  G. Grubb,et al.  Insertion site complications during the first year of NORPLANT use. , 1990, Contraception.

[17]  C. Shively,et al.  From menarche to menopause: coronary artery atherosclerosis and protection in cynomolgus monkeys. , 1989, American journal of obstetrics and gynecology.

[18]  S. Monroe,et al.  Clinical evaluation of the Capronor contraceptive implant: preliminary report. , 1989, American journal of obstetrics and gynecology.

[19]  A. Faúndes,et al.  The clinical performance of NORPLANT implants over time: a comparison of two cohorts. , 1988, Studies in family planning.

[20]  I. Sivin.  International experience with NORPLANT and NORPLANT-2 contraceptives. , 1988, Studies in family planning.

[21]  B. Affandi,et al.  Serum lipids in Norplant implants users: a cross-sectional study. , 1987, Contraception.

[22]  H. Croxatto,et al.  Recovery of fertility and outcome of planned pregnancies after the removal of Norplant subdermal implants or Copper-T IUDs. , 1987, Contraception.

[23]  M. Haukkamaa.  Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment. , 1986, Contraception.

[24]  A. Faúndes,et al.  Abnormal endocrine profile among women with confirmed or presumed ovulation during long-term Norplant use. , 1986, Contraception.

[25]  K. A. Abdullah,et al.  Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth. , 1985, Contraception.

[26]  M. Shaaban,et al.  Effect of early postpartum use of the contraceptive implants, NORPLANT, on the serum levels of immunoglobulins of the mothers and their breastfed infants. , 1985, Contraception.

[27]  H. Croxatto,et al.  Fertility regulation in nursing women: VII. Influence of NORPLANT levonorgestrel implants upon lactation and infant growth. , 1985, Contraception.

[28]  W. Ledger,et al.  Contraceptive efficacy of bioabsorbable pellets of norethindrone (NET) as subcutaneous implants: Phase II clinical study , 1985, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

[29]  A. Faúndes,et al.  Anovulation, inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of Norplant implants. , 1985, Contraception.

[30]  M. Shaaban,et al.  Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation. , 1984, Contraception.

[31]  M. Shaaban,et al.  Effect of subdermal levonorgestrel contraceptive implants, Norplant, on liver functions. , 1984, Contraception.

[32]  R. Krauss,et al.  Long-term reversible contraception with levonorgestrel-releasing Silastic rods. , 1984, American journal of obstetrics and gynecology.

[33]  T. Pardthaisong.  Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysis , 1984, Journal of Biosocial Science.

[34]  I. Sivin,et al.  Three-year experience with NORPLANT subdermal contraception. , 1983, Fertility and sterility.

[35]  I. Sivin,et al.  A four-year clinical study of NORPLANT implants. , 1983, Studies in family planning.

[36]  M. Fayad,et al.  Serum cortisol in women users of subdermal levonorgestrel implants. , 1983, Contraceptive delivery systems.

[37]  H. Croxatto,et al.  Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD. , 1983, Contraception.

[38]  C. Nilsson,et al.  Menstrual blood loss with contraceptive subdermal levonorgestrel implants. , 1981, Fertility and sterility.

[39]  J. Teachman,et al.  Contraceptive Delivery Systems , 1980 .

[40]  I. Sivin.  Copper T IUD use and ectopic pregnancy rates in the United States. , 1979, Contraception.

[41]  H. Croxatto,et al.  Clinical chemistry in women treated with progestogen implants. , 1978, Contraception.

[42]  H. Croxatto,et al.  Clinical assessment of subdermal implants of megestrol acetate, d-norgestrel, and norethindrone as a longterm contraceptive in women. , 1975, Contraception.

[43]  H. Croxatto,et al.  Fertility control in women with a progestogen released in microquantities from subcutaneous capsules. , 1969, American journal of obstetrics and gynecology.